BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 20226028)

  • 21. 186Re-HEDP in the treatment of patients with inoperable osteosarcoma.
    Syed R; Bomanji J; Nagabhushan N; Kayani I; Groves A; Waddington W; Cassoni A; Ell PJ
    J Nucl Med; 2006 Dec; 47(12):1927-35. PubMed ID: 17138735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
    Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol.
    Uhl M; Edler L; Jensen AD; Habl G; Oelmann J; Röder F; Jäckel O; Debus J; Herfarth K
    Radiat Oncol; 2014 Apr; 9():100. PubMed ID: 24774721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotherapy in the treatment of primary osteosarcoma--a single center experience.
    Oertel S; Blattmann C; Rieken S; Jensen A; Combs SE; Huber PE; Bischof M; Kulozik A; Debus J; Schulz-Ertner D
    Tumori; 2010; 96(4):582-8. PubMed ID: 20968138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma.
    Ciernik IF; Niemierko A; Harmon DC; Kobayashi W; Chen YL; Yock TI; Ebb DH; Choy E; Raskin KA; Liebsch N; Hornicek FJ; Delaney TF
    Cancer; 2011 Oct; 117(19):4522-30. PubMed ID: 21448934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy.
    Blattmann C; Oertel S; Thiemann M; Dittmar A; Roth E; Kulozik AE; Ehemann V; Weichert W; Huber PE; Stenzinger A; Debus J
    Radiat Oncol; 2015 Jul; 10():146. PubMed ID: 26178881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of clinical experiences on carbon ion radiotherapy at NIRS.
    Tsujii H; Mizoe JE; Kamada T; Baba M; Kato S; Kato H; Tsuji H; Yamada S; Yasuda S; Ohno T; Yanagi T; Hasegawa A; Sugawara T; Ezawa H; Kandatsu S; Yoshikawa K; Kishimoto R; Miyamoto T
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S41-9. PubMed ID: 15971308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fast neutron radiotherapy in the treatment of limb-salvage surgery in patients with osteosarcoma].
    Takada N; Hodaka E; Umeda T; Hayashi H
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1405-11. PubMed ID: 3473977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg ion therapy center using the raster scanning technique.
    Rieken S; Habermehl D; Nikoghosyan A; Jensen A; Haberer T; Jäkel O; Münter MW; Welzel T; Debus J; Combs SE
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e793-801. PubMed ID: 21300464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical proton radiation therapy research at the Francis H. Burr Proton Therapy Center.
    DeLaney TF
    Technol Cancer Res Treat; 2007 Aug; 6(4 Suppl):61-6. PubMed ID: 17668954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial.
    Combs SE; Kieser M; Habermehl D; Weitz J; Jäger D; Fossati P; Orrechia R; Engenhart-Cabillic R; Pötter R; Dosanjh M; Jäkel O; Büchler MW; Debus J
    BMC Cancer; 2012 Apr; 12():137. PubMed ID: 22472035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.
    Hundsdoerfer P; Albrecht M; Rühl U; Fengler R; Kulozik AE; Henze G
    Eur J Cancer; 2009 Sep; 45(14):2447-51. PubMed ID: 19596190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC).
    Takahashi W; Nakajima M; Yamamoto N; Yamashita H; Nakagawa K; Miyamoto T; Tsuji H; Kamada T; Fujisawa T
    Cancer; 2015 Apr; 121(8):1321-7. PubMed ID: 25641119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer.
    Mizoe JE; Tsujii H; Kamada T; Matsuoka Y; Tsuji H; Osaka Y; Hasegawa A; Yamamoto N; Ebihara S; Konno A;
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):358-64. PubMed ID: 15380567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term survival of two patients with inoperable post-irradiation osteosarcoma treated with carbon-ion radiotherapy: a case report.
    Shiba S; Okamoto M; Yanagawa T; Kohama I; Shibuya K; Okazaki S; Miyasaka Y; Chikuda H; Ohno T
    Radiat Oncol; 2022 Apr; 17(1):68. PubMed ID: 35379287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Present status of carbon ion radiotherapy for malignant tumors].
    Sugahara S; Kamada T
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1795-800. PubMed ID: 19920380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbon ion radiotherapy as definitive treatment in non-metastasized pancreatic cancer: study protocol of the prospective phase II PACK-study.
    Liermann J; Naumann P; Hommertgen A; Pohl M; Kieser M; Debus J; Herfarth K
    BMC Cancer; 2020 Oct; 20(1):947. PubMed ID: 33004046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton and carbon ion radiotherapy for primary brain tumors and tumors of the skull base.
    Combs SE; Kessel K; Habermehl D; Haberer T; Jäkel O; Debus J
    Acta Oncol; 2013 Oct; 52(7):1504-9. PubMed ID: 23962241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.